Myositis Treatment Market - Top Companies and Manufacturers

Companies Dominating the Myositis Treatment Landscape

Baxter International, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Eli Lilly and Company
Novartis AG
Sanofi-aventis Groupe
Abbott Laboratories
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Siemens Healthcare GmbH
Pfizer Inc.
Becton, Dickinson and Company
IBSRELA
Indegene

Browse Key Market Insights with Data Illustration:

Myositis Treatment Market Size & Share, Forecast Report 2036

In the News

IBSRELA the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by the biopharmaceutical company Ardelyx. The first Ardelyx product to receive approval from the US Food and Drug Administration is IBSRELA.
Indegene a provider of technology-driven healthcare solutions, & meta Me Health, a maker of Regulora and a Prescription Digital Therapeutics (PDT) business, teamed up to offer Regulora as a remedy for irritable bowel syndrome-related stomach pain (IBS).

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of myositis treatment is evaluated at USD 686.2 Million.

The myositis treatment market size was valued at USD 650 Million in 2023 and is projected to exceed USD 1.1 Billion by the end of 2036, expanding at over 4.2% CAGR during the forecast period i.e., between 2024-2036. Growing geriatric population and increasing cases of myositis amongst the older population are estimated to boost the market growth.

North America industry will dominate 37% revenue share by 2036, led by increasing frequency of musculoskeletal disorders amongst several people.

Baxter International, Inc., Eli Lilly and Company, Novartis AG, Sanofi-aventis Groupe, Abbott Laboratories, Johnson & Johnson Services, Inc., Merck & Co., Inc., Siemens Healthcare GmbH, Pfizer Inc., Becton, Dickinson and Company, IBSRELA, Indegene

Myositis Treatment Market - Top Companies and Manufacturers

Companies Dominating the Myositis Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the myositis treatment market?

What are the factors driving the myositis treatment landscape?

Which region held the largest myositis treatment industry share?

Who are the key players in the myositis treatment sector?